MARKET

OPTN

OPTN

OptiNose
NASDAQ

Real-time Quotes | Nasdaq Last Sale

8.86
+0.22
+2.55%
Opening 12:43 12/10 EST
OPEN
8.74
PREV CLOSE
8.64
HIGH
8.92
LOW
8.60
VOLUME
80.06K
TURNOVER
--
52 WEEK HIGH
11.66
52 WEEK LOW
4.443
MARKET CAP
367.59M
P/E (TTM)
-3.2856
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of OPTN and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

OPTN News

  • Optinose to Present at the Piper Jaffray 31st Annual Healthcare Conference
  • GlobeNewswire.11/26 21:01
  • Healthcare On The March
  • Seeking Alpha - Article.11/21 17:07
  • OptiNose Prices 5.5M Share Common Stock Offering At $9.75/Share
  • Benzinga.11/21 14:01
  • The Daily Biotech Pulse: Patent Win For Cellectis, Hepion Proves Efficacy In Animal Model, Job Cuts At Neon
  • Benzinga.11/21 12:22

More

Industry

Biotechnology & Medical Research
+0.66%
Pharmaceuticals & Medical Research
+0.69%

Hot Stocks

Name
Price
%Change

About OPTN

OptiNose, Inc. is a pharmaceutical company. The Company is focused on the development and commercialization of products for patients treated by ear, nose and throat, or ENT, and allergy specialists. The Company’s products candidates include XHANCE (Nasal Polyps), XHANCE (Chornic Sinusitis) OPN-300, OPN-021, and other. The Company’s lead product, XHANCE (fluticasone propionate) nasal spray, utilizes breath powered exhalation delivery system (EDS), to deliver a topically acting and potent anti-inflammatory corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. XHANCE has a differentiated clinical profile with the potential to become part of the standard of care for this disease because it is able to deliver medication to the primary site of inflammation.
More

Webull offers OptiNose Inc (OPTN) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.